Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001) [Phase 1]

View source ↗

Summary

Phase 1 trial updating safety, tolerability, and pharmacokinetics of MK-7252 in healthy adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK-7252

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pharmacokinetics, Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-01-09